Wells Fargo Downgrades Oscar Health to Equal-Weight, Lowers Price Target to $16

Benzinga · 4d ago
Wells Fargo analyst Stephen Baxter downgrades Oscar Health (NYSE:OSCR) from Overweight to Equal-Weight and lowers the price target from $20 to $16.